|
End-of-day quote
Bulgaria S.E.
24/03/2026
|
5-day change | 1st Jan Change | ||
| 176.40 EUR | -11.91% |
|
-.--% | -7.43% |
| 28/09 | AbbVie Receives U.S. FDA Approval For JUVMO For Parkinson's Disease | CI |
| 28/09 | US drugmakers turn to China for licensing deals | RE |
| Market Cap | 47TCr 41TCr 39TCr 35TCr 67TCr 45,16900Cr 67TCr 4,68600Cr 1,81000Cr 23,04900Cr 1,76700Cr 1,72800Cr 74,06600Cr | P/E 2026 * |
33.7x | P/E 2027 * | 25.1x |
|---|---|---|---|---|---|
| Enterprise Value | 53TCr 47TCr 44TCr 40TCr 75TCr 51,08100Cr 76TCr 5,29900Cr 2,04700Cr 26,06600Cr 1,99800Cr 1,95500Cr 83,76100Cr | EV / Sales 2026 * |
7.87x | EV / Sales 2027 * | 7.12x |
| Free-Float |
95.71% | Yield 2026 * |
2.61% | Yield 2027 * | 2.71% |
Last Transcript: AbbVie Inc.
| 1 day | -11.91% | ||
| Current year | -7.43% |
| Current year | 176.4 |  | 200.25 |
| 1 year | 176.4 | | 200.25 |
| 3 years | 164.86 | | 200.25 |
| 5 years | 119.2 | | 200.25 |
| 10 years | 119.2 | | 200.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 23/06/2022 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 74 | 01/01/2013 |
Ed Rapp
BRD | Director/Board Member | 69 | 01/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.91% | -.--% | - | - | 47TCr | |
| +0.11% | +1.71% | +63.52% | +117.61% | 1,05500Cr | |
| +0.27% | +0.92% | +51.33% | +73.35% | 65TCr | |
| +0.73% | +0.68% | +20.70% | +74.90% | 47TCr | |
| -1.36% | -2.58% | +40.20% | +42.33% | 35TCr | |
| +1.34% | +4.53% | +23.37% | +29.55% | 27TCr | |
| -0.48% | -0.54% | +13.56% | +13.50% | 26TCr | |
| +0.85% | +6.35% | +53.17% | +54.39% | 22TCr | |
| +0.85% | +1.10% | +35.78% | +101.82% | 19TCr | |
| -0.30% | -2.98% | -27.62% | -61.28% | 17TCr | |
| Average | -1.08% | +0.52% | +30.45% | +49.57% | 40.43TCr | |
| Weighted average by Cap. | -1.40% | +1.00% | +40.69% | +69.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76TCr 5.95TCr 5.62TCr 5.1TCr 9.58TCr 6,48900Cr 9.63TCr 67TCr 26TCr 3,31100Cr 25TCr 25TCr 10,64000Cr | 7.35TCr 6.46TCr 6.11TCr 5.54TCr 10TCr 7,05500Cr 10TCr 73TCr 28TCr 3,60000Cr 28TCr 27TCr 11,56800Cr |
| Net income | 1.41TCr 1.24TCr 1.17TCr 1.06TCr 1.99TCr 1,35000Cr 2TCr 14TCr 5.41TCr 69TCr 5.28TCr 5.17TCr 2,21400Cr | 1.9TCr 1.68TCr 1.58TCr 1.44TCr 2.7TCr 1,82800Cr 2.71TCr 19TCr 7.32TCr 93TCr 7.15TCr 7TCr 2,99800Cr |
| Net Debt | 6.16TCr 5.42TCr 5.12TCr 4.65TCr 8.73TCr 5,91200Cr 8.78TCr 61TCr 24TCr 3,01700Cr 23TCr 23TCr 9,69500Cr | 5.31TCr 4.67TCr 4.42TCr 4TCr 7.52TCr 5,09600Cr 7.57TCr 53TCr 20TCr 2,60100Cr 20TCr 20TCr 8,35700Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
- 4AB Stock
Select your edition
All financial news and data tailored to specific country editions
